NEW YORK, May 1st, 2024 12:00 PM EDT - TikaMobile, a leader in transforming field medical efforts for the Life Science industries, is excited about the launch of its innovative companion app for TikaMSL, a platform for strategic KOL engagement. Designed for iPhone, the companion mobile solution empowers Medical Science Liaisons (MSLs) and medical affairs professionals with seamless access to critical information while traveling.
NEW YORK, August 25, 2023 10:00 EDT - Software company TikaMobile has launched conversational and generative AI solutions, powered by ChatGPT that enhance the efficiency of field teams. The advanced AI solution covers three primary areas: publication analysis, medical insights and engagement analysis, and SOP and field info guidance.
The primary role of a medical science liaison (MSL) is to develop, nurture, and maintain relationships with key opinion leaders (KOLs). To do this, an MSL has to properly prepare for meetings with KOLs to ensure successful outcomes. Lack of preparation can lead to ineffective meetings and frustration for both the MSL and KOL.
Medical Science Liaisons (MSLs) are consistently looking for ways to increase the effectiveness of their engagements with Key Opinion Leaders (KOLs). To do this, many Medical Affairs teams are creating in-depth KOL engagement plans, capturing insights, and measuring a KOL’s movement along a development continuum.
Medical Science Liaisons (MSLs) work to foster and maintain relationships with Healthcare Providers (HCPs) and Key Opinion Leaders (KOLs) who specialize in the disease or therapeutic area their product treats. As such, Medical Affairs teams provide crucial scientific value to pharmaceutical, biotech, and medical device companies.
Field inventory management, including medical trunk stock and consignment inventory, is an important business practice for medical device manufacturers. These practices provide flexibility for hospitals and physicians to try new and existing products. For device manufacturers these can be critical, especially for newer economically unproven products where physicians might be reluctant to try Buy and Bill.
